Market News AIOpen the app

Mizuho Securities raised its price target for Biogen to $271, up from $241.

OpinionRead the original at marketscreener.com
Good for BIIB

Mizuho raised its share target, signaling a more favorable analyst view of Biogen. The rating stayed Outperform, but the story reports no new company results.

BIIB · Biogen Inc.

AI read · Good for BIIB

The AI's read

The higher target and unchanged rating show Mizuho sees more room for Biogen's shares to rise. The story adds no new company results or product changes, so this is an analyst view rather than a business update.

Get alerts for BIIB

Follow Biogen Inc. (BIIB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BIIB
Free on the App Store and Google Play, or on the web.